2025 Advocacy Priorities
Where We Stand
The American College of Physicians supports increasing accessibility and affordability of prescription drugs. Medications can only be as effective as our patients’ ability to access them. We support efforts to help control the rising cost of prescription drugs and ensure an adequate supply of medications.
Policies
- Policy Recommendations to Promote Prescription Drug Competition September 2020
- Position Statement on Prescription Drug Recalls 4/20/2020
- Mitigating the Negative Impact of Step Therapy Policies and Nonmedical Switching of Prescription Drugs on Patient Safety: An 바카라 사리트 Position Paper 2020
- Policy Recommendations for Pharmacy Benefit Managers to Stem the Escalating Costs of Prescription Drugs 2019
- Policy Recommendations for Public Health Plans to Stem the Escalating Costs of Prescription Drugs 2019
- Stemming the Escalating Cost of Prescription Drugs 2016
Latest Advocacy Efforts
- Letter바카라 사리트 Comment Letter on Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients 5/6/2025
- Letter바카라 사리트’s Letter of Support for the Capping Prescription Costs Act of 2025 3/31/2025
- Letter바카라 사리트's Letter to Rep. Schweikert Raising Concerns About H.R. 238, the Healthy Technology Act of 2025 3/7/2025
- Testimony바카라 사리트 Statement to the House Energy & Commerce Health Subcommittee on Pharmacy Benefit Managers (PBMs) Hearing 2/26/2025
- Testimony바카라 사리트 Statement to House WM Health Subcommittee on Modernizing American Health Care: Creating Healthy Options and Better Incentives for Patients 2/11/2025
- Letter바카라 사리트 Letter to Internal Revenue Service, Employee Benefits Security Administration, and Department of Health and Human Services Regarding the Enhancing Coverage of Preventive Services Under the ACA Proposed Rule 12/16/2024
- Letter바카라 사리트 Response to CMS RFI on Medicare $2 Drug List Model 12/9/2024
Search the 바카라 사리트 Policy Library
To access everything 바카라 사리트 has said related to Medicare reform issues search all policy statements, copies of testimony, and letters to government and non-government officials.